SCHEDULE: Advanced Biomed Inc. Ownership Update Filed

A Schedule 13G filing reveals updated beneficial ownership details for Advanced Biomed Inc. common stock.

Summary

• This filing is a Schedule 13G, which reports beneficial ownership of securities. It indicates that Advance On Ventures Limited (AOVL) and Chen Yi Lee are jointly filing.
• AOVL, a British Virgin Islands company, holds 109,200 shares, representing 6.6% of the outstanding common stock.
• Chen Yi Lee, a citizen of Taiwan and the sole director of AOVL, also directly holds 14,640 shares.
• Collectively, Chen Yi Lee has sole voting and dispositive power over the 109,200 shares held by AOVL and directly holds 14,640 shares.
• The total beneficial ownership reported by Chen Yi Lee is 123,840 shares, representing 7.5% of the class.
• The outstanding shares figure of 1,652,133 is based on the Issuer's Definitive Proxy Statement filed on June 4, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an update on beneficial ownership rather than a financial performance report.

Positives

• Clear disclosure of beneficial ownership, providing transparency to the market.
• Chen Yi Lee's direct and indirect holdings combined represent a significant stake (7.5%), potentially indicating strong conviction in the company.

Negatives

• The filing does not contain financial performance data, making it difficult to assess the company's operational health.
• The information is primarily administrative, not indicative of business growth or strategic advancements.

Risks

• Concentration of ownership among a few entities could lead to potential market influence or control issues.
• Reliance on a single individual (Chen Yi Lee) for significant voting and dispositive power could pose a governance risk if not managed appropriately.

Future Outlook

No forward-looking statements or guidance are provided in this Schedule 13G filing.

Management Comments

• Chen Yi Lee, as the sole director of Advance On Ventures Limited, has sole voting and dispositive power over the shares held by AOVL.
• Chen Yi Lee also directly holds 14,640 shares of Common Stock.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual holders to report their stakes. This filing provides an update on ownership for Advanced Biomed Inc., but does not offer insights into the company's operational performance or market position relative to peers.

Stakeholder Impact

• Shareholders gain clarity on the significant beneficial ownership held by Advance On Ventures Limited and Chen Yi Lee.
• The concentration of ownership may influence future corporate actions or strategic decisions.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership of Advanced Biomed Inc. common stock.

Key Dates

Keywords

beneficial ownership, Schedule 13G, stock ownership, voting power, dispositive power, corporate filing, insider holding